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Abstract
Background. Obstructive nephropathy decreases renal
blood flow (RBF) and glomerular filtration rate (GFR),
causing tubular abnormalities, such as urinary concentrat-
ing defect, as well as increasing oxidative stress. This study
aimed to evaluate the effects of N-acetylcysteine (NAC)
on renal function, as well as on the protein expression of
aquaporin 2 (AQP2) and endothelial nitric oxide synthase
(eNOS), after the relief of bilateral ureteral obstruction
(BUO).
Methods. Adult male Wistar rats were divided into four
groups:sham(shamoperated);shamoperated+440mg/kg
body weight (BW) of NAC daily in drinking water, started
2 days before and maintained until 48 h after the surgery;
BUO (24-h BUO only); BUO + NAC-pre (24-h BUO plus
440 mg/kg BW of NAC daily in drinking water started
2 days before BUO); and BUO + NAC-post (24-h BUO
plus 440 mg/kg BW of NAC daily in drinking water started
on the day of BUO relief). Experiments were conducted
48 h after BUO relief.
Results.Serumlevels ofthiobarbituricreactivesubstances,
which are markers of lipid peroxidation, were significantly
lower in NAC-treated rats than in the BUO group rats.
The administration of NAC provided significant protection
against post-BUO GFR drops and reductions in RBF. Re-
nal cortices and BUO rats presented decreased eNOS pro-
tein expression of eNOS in the renal cortex of BUO group
rats, whereas it was partially recovered in BUO + NAC-
pre group rats. Urine osmolality was significantly lower
in BUO rats than in sham group rats or NAC-treated rats,
the last also presenting less interstitial fibrosis. Post-BUO
downregulation of AQP2 protein expression was averted in
the BUO + NAC-pre group rats.
Conclusions. This study demonstrates that NAC adminis-
tration ameliorates the renal function impairment observed
48 h after the relief of 24-h BUO. Oxidative stress is im-
portant for the suppression of GFR, RBF, tissue AQP2 and
eNOS in the polyuric phase after the release of BUO.
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Introduction
Obstructive nephropathy decreases renal blood flow (RBF)
and the glomerular filtration rate (GFR), thereby causing
tubularabnormalities,suchasurinaryconcentratingdefect,
as well as having the potential to increase oxidative stress
[1]. Functional recovery typically occurs within the first
7–10 days after the obstruction is relieved, although some
patients require dialysis for a period of weeks before re-
covering full renal function [2]. In animal studies, it has
been demonstrated that there is long-term downregulation
of aquaporin 2 (AQP2) protein expression after bilateral
ureteral obstruction (BUO), suggesting that dysregulation
of AQPs in the collecting duct plays a role in the long-term
polyuria and impaired urinary concentrating ability that are
associated with obstructive nephropathy [3–5]. A selective
decrease in post-obstruction urinary AQP2 excretion has
also been observed in patients undergoing pyeloplasty for
the treatment of congenital unilateral hydronephrosis re-
sulting from ureteropelvic junction obstruction [6].
Reactiveoxygenmetabolitesarebelievedtobeimportant
mediators of various forms of acute kidney injury, such as
ischaemic renal failure, radiocontrast nephrotoxicity and
ureteral obstruction [7–10]. Acute loss of renal function
and impaired urinary excretion lead to accumulation of
advanced glycation end products, as well as oxidation and
high levels of nitration-free adducts, in the plasma of rats
subjected to BUO [11].
Previous studies have shown that, in rats with
ischaemia/reperfusion-induced acute kidney injury, treat-
mentwiththeantioxidantN-acetylcysteine(NAC)improves
renal haemodynamics, upregulating the protein expression
of endothelial nitric oxide synthase (eNOS) and AQP2,
thereby protecting against urinary concentrating defect [7].
Although the mechanism by which NAC protects organs
primarily involves the scavenging of oxygen-free radicals
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(eitherdirectlyorbyincreasingintracellularconcentrations
of glutathione), the greater NO viability resulting from in-
creased eNOS protein expression also plays a role [12].
The purpose of the present study was to evaluate a pro-
tective effect on the renal function of rats after the relief of
BUO.
Methods
Experimental animals
Adult male Wistar rats weighing 150–200 g were obtained
from the animal facilities of the University of S˜ ao Paulo
School of Medicine. Selected rats were treated with NAC
[440 mg/kg body weight (BW) in drinking water] [7], ini-
tiated either 2 days before BUO or on the day of the relief
of the obstruction.
Induction of bilateral ureteral obstruction
Animals were anaesthetized with 50 mg/kg BW of sodium
pentobarbital, administered intraperitoneally. Through a
midline abdominal incision, both ureters were exposed. We
encasedeachureterinasectionofpolyethylenetubing(PE-
50), after which we placed two ligatures, 5 mm apart, in the
upper two-thirds of each, using 5-0 silk to tighten the tub-
ing and occlude the ureter. After having recovered from
the anaesthesia, the animals were returned to their original
cages and given free access to water and standard rat chow
(Nuvilab, Colombo, Brazil). The ligation, together with the
tubing, was removed after 24 h.
The following groups were studied:
• sham operated and untreated (n = 6);
• sham operated and treated with 440 mg/kg BW of NAC
daily in drinking water, started 2 days before BUO and
maintained until 48 h after the surgery (n = 7);
• 24-h BUO and untreated (n = 6);
• 24-h BUO plus 440 mg/kg BW of NAC daily in drinking
water, started 2 days before BUO and maintained until
48 h after the relief of the obstruction (n = 7);
• 24-h BUO plus 440 mg/kg BW of NAC daily in drinking
water, started on the day on which the obstruction was
relieved and maintained for an additional 48 h thereafter
(n = 6).
Clearance studies and collection of blood/urine samples
To determine GFRs, inulin clearance studies were con-
ducted. On the day of the experiment, the animals were
anaesthetized intraperitoneally with sodium pentobarbital
(50 mg/kg BW). The trachea was cannulated with a PE-
240 catheter, and spontaneous breathing was maintained.
To control mean arterial pressure and allow blood sam-
pling, a PE-60 catheter was inserted into the right carotid
artery. For the infusion of inulin and fluids, another PE-60
catheter was inserted into the left jugular vein. In order to
collect urine samples, a suprapubic incision was made, and
the urinary bladder was cannulated with a PE-240 catheter.
After the surgical procedure had been completed, a loading
dose of inulin (100 mg/kg BW diluted in 0.9% saline) was
administeredthroughthejugularvein.Subsequently,acon-
stant infusion of inulin (10 mg/kg BW in 0.9% saline) was
started and was continued at 0.04 ml/min throughout the
experiment. Three urine samples were collected at 30-min
intervals.Bloodsampleswereobtainedatthebeginningand
at the end of the experiment. Blood and urine inulin were
determinedusingtheanthronemethod.GFRsareexpressed
as ml/min/100 g.
Renal blood flow
To measure RBF, a midline incision was made. We then
carefully dissected the left renal pedicle and isolated the
renal artery, taking precautions to avoid disturbing the
renal nerves. An ultrasonic flow probe (T110; Transonic
Systems, Bethesda, MD, USA) was placed around the ex-
posed renal artery. RBF was measured using an ultrasonic
flowmeter (T106; Transonic Systems) and is expressed as
ml/min. Renal vascular resistance was calculated by di-
viding the blood pressure by RBF and is expressed in
mmHg/ml/min/100 g BW.
Tissue sample collection/preparation
At the end of the experiments, the left kidney was flushed
with saline and perfused in situ with the Duboscq-Brazil
solution. The renal tissue was then fixed, after which it
was weighed, and two sections were postfixed in a buffered
10% formaldehyde solution. The material was embedded
in paraffin for the assessment of glomerular injury, as well
as of interstitial injury in the renal cortex. The right kidney
wasremovedandwasdividedintocortex,outermedullaand
inner medulla. The kidney sections were frozen in liquid
nitrogen and stored at −70◦C.
Urine osmolality
Urine osmolality was determined using a freezing point
osmometer (3D3; Advanced Instruments, Norwood, MA,
USA) and is expressed as mOsm/kg H2O.
Reactive oxygen metabolites
Serum levels of thiobarbituric acid reactive substances
(TBARS), which are markers of lipid peroxidation, were
determined using the thiobarbituric acid assay. In brief, a
0.2-mlserumsamplewasdilutedin0.8mlofdistilledwater.
Immediately thereafter, 1 ml of 17.5% trichloroacetic acid
was added. Following the addition of 1 ml of 0.6% thio-
barbituric acid, pH 2, the sample was placed in a boiling
water bath for 15 min, after which it was allowed to cool.
Subsequently, 1 ml of 70% trichloroacetic acid was added,
and the mixture was incubated for 20 min. The sample
was then centrifuged for 15 min at 2000 rpm. The optical
density of the supernatant was read at 534 nm against a
reagent blank using a spectrophotometer. The quantity of
TBARS wascalculated usingamolarextinction coefficient
of 1.56 × 105 M−1 cm−1. Serum levels of TBARS are ex-
pressed as nmol/ml [13]. In order to validate that the used
anaesthetic, which is also a barbituric acid compound, does
not interfere with the assay, an additional group of six ratsN-acetylcysteine protects against renal injury 3069
was anaesthetized with ether and blood was obtained by
cardiac puncture to TBARS determination.
Preparation of membrane fractions for the determination
of aquaporin 2 protein expression
InordertoquantifyAQP2proteinexpression,medullasam-
pleswereprepared.Thesampleswerehomogenizedusinga
Teflon pestle glass homogenizer (Schmidt and Co., Frank-
furt am Main, Germany) in an ice-cold isolation solution
of 200 mM mannitol, 80 mM HEPES and 41 mM KOH,
pH7.5,alsocontainingaproteaseinhibitorcocktail(Sigma
Chemical Company, St. Louis, MO, USA).
The homogenates were centrifuged at a low speed
(2000 × g) for 15 min at 4◦C to remove nuclei and cell
debris. Subsequently, the supernatants were centrifuged at
100 000 × g f o r1ha t4 ◦C using a Ti70i rotor (Beck-
man Coulter, Fullerton, CA, USA) to produce a pellet
that contained membrane fractions enriched with plasma
membranes and intracellular vesicles. The pellets were sus-
pended in an isolation solution.
Preparation of samples for the determination of
endothelial nitric oxide synthase protein expression
In order to quantify eNOS protein expression, kidney sec-
tions were prepared. The sections were homogenized using
a Teflon pestle glass homogenizer (Schmidt and Co.) in an
ice-cold isolation solution of 200 mM mannitol, 80 mM
HEPES and 41 mM KOH, pH 7.5, also containing a pro-
tease inhibitor cocktail (Sigma). The homogenates were
centrifuged at a low speed (3000 × g) for 15 min at 4◦Ct o
removenucleiandcelldebris.Thepelletsweresuspendedin
an isolation solution with protease inhibitors. Protein quan-
tities were determined using the Bradford assay method.
Electrophoresis and immunoblotting
To determine AQP2 protein expression, samples of
membrane fractions were run on 12.5% polyacrylamide
minigels. After transfer by electroelution to polyvinyli-
dene difluoride membranes (Poly-Screen, PVDF Trans-
fer; Amersham Bioscience, Little Chalfont, UK), these
blots were blocked for 1 h with 5% milk and 0.1%
Tween 20 in phosphate-buffered saline (8.7 g/l of NaCl,
7.2 mM dibasic phosphate and 2.8 mM monobasic phos-
phate). The blots were then incubated with an anti-AQP2
antibody (1:2000). The labelling was visualized using
a horseradish peroxidase-conjugated secondary antibody
(anti-rabbit IgG, diluted 1:2000, or anti-goat IgG, diluted
1:5000;Sigma)usinganenhancedchemiluminescencesys-
tem(AmershamPharmaciaBiotech,Piscataway,NJ,USA).
For the evaluation of the eNOS isoform, 100 µgo f
total protein from each sample was separated on an 8%
polyacrylamide gel and then transferred to a polyvinyli-
denedifluoridemembrane.Immunoblottingwasperformed
using an anti-eNOS antibody diluted 1:2000 in Tris-
buffered saline and Tween 0.1%. Immunodetection was ac-
complished using the appropriate anti-mouse horseradish
peroxidase-conjugated secondary antibody (diluted 1:2000
in Tris-buffered saline and 0.1% Tween) and the enhanced
chemiluminescence kit (Amersham).
As a loading control, blots were incubated with an actin
antibody (1:3000, Santa Cruz Biotechnology, Santa Cruz,
CA,USA).Thelabellingwasvisualizedusingahorseradish
peroxidase-conjugated anti-goatantibody(1:5000;Sigma).
For AQP2 and eNOS, values are expressed as a percent-
age of normal protein expression.
Quantification of protein levels
InordertodeterminethelevelsofAQP2andeNOSprotein,
the enhanced chemiluminescence films presenting bands
within the linear range were scanned using an image anal-
ysis system (ImageMaster VDS; Pharmacia Biotech, Upp-
sala,Sweden).Throughdensitometricanalysis,thesebands
were normalized to actin protein abundance.
Preparation of histological sections
Paraffin sections of perfused/fixed kidneys were stained
withhaematoxylinandeosinforhistologicalanalysisunder
light microscopy.
Fractional interstitial area
The readers of the interstitial area were blinded to study
group. The fractional interstitial area of the renal cortex
was determined through morphometry using a light camera
connectedtoanimageanalyser(KontronElectronicSystem
KS 300, Eching, Germany). In each renal cortex section,
20 grid fields (measuring 0.174 mm2 each) were evaluated.
Interstitial areas were first manually encircled on a video
screen and then determined by computerized morphometry
in control rats, in rats subjected to BUO and receiving NAC
on the day of BUO relief, as well as in rats subjected to
BUO only (n = 6 in each group).
Statistical analysis
Resultsarepresentedasmean±SEM.Inordertodetermine
the degree of injury resulting from the BUO, the untreated
group was compared with the NAC-treated group using
analysis of variance (ANOVA) and the Student–Newman–
Keuls post hoc test using GraphPad Prism (version 3.0) and
Stata (version 8.0) statistical software. The comparisons
between NAC-treated and untreated rats were made using
unpaired t-tests. The interstitial fibrosis area was analysed
using the Mann–Whitney test. A P value <0.05 was con-
sidered statistically significant.
Results
Bilateral ureteral obstruction is associated with
reductions in glomerular filtration rate and renal blood
flow that improve after N-acetylcysteine administration
The results of the clearance studies are presented in
Table 1. As can be seen, although 24-h BUO provoked
an increase in serum levels of TBARS, this shows that3070 M. H. M. Shimizu et al.
Table 1. Renal function and haemodynamics at 48 h after the relief of bilateral ureteral obstruction
GFR Uosm RVR Serum TBARS
(ml/min/100 g) (mOsm/kg H2O) BP (mmHg) RBF (ml/min) (mmHg/ml/ min/100g) (nmol/ml)
Sham 0.83 ± 0.05a 919 ± 65a 109 ± 3a 2.93 ± 0.12b 15.34 ± 0.44a 2.80 ± 0.14d
Sham + NAC 1.02 ± 0.03a,c 851 ± 34a 113 ± 4a 2.94 ± 0.02b 18.52 ± 0.80a 2.00 ± 0.06a
BUO 0.41 ± 0.09 409 ± 19 141 ± 52 . 2 5 ± 0.11 53.07 ± 9.51 3.74 ± 0.31
BUO + NAC-pre 0.81 ± 0.06a 763 ± 60a 131 ± 43 . 0 9 ± 0.16a 23.00 ± 0.85a 2.17 ± 0.39b
BUO + NAC-post 0.67 ± 0.06b 737 ± 30b 128 ± 52 . 7 6 ± 0.13b 20.14 ± 0.81a 1.75 ± 0.31a
GFR, glomerular filtration rate; Uosm, urine osmolality; BP, blood pressure; RBF, renal blood flow; RVR, renal vascular resistance; TBARS, thiobar-
bituric acid reactive substances; Sham, sham-operated group; Sham plus NAC started 2 days prior to surgery; BUO, 24-h bilateral ureteral obstruction
(BUO) only group; BUO + NAC-pre, 24-h BUO plus NAC started 2 days prior to obstruction; BUO + NAC-post, 24-h BUO plus NAC started on the
day of the relief of the obstruction.
aP < 0.001 versus BUO; bP < 0.01 versus BUO; cP < 0.05 versus sham; dP < 0.05 versus BUO.
Fig. 1. Semiquantitative immunoblotting of kidney samples 48 h after the relief of BUO. (A) Densitometric analysis of all samples from sham-operated,
untreated rats, rats subjected to BUO and left untreated, and rats in which NAC was started prior to BUO. The rats subjected to BUO and left untreated
presented decreased eNOS protein expression. Levels of eNOS protein expression were partially restored in the rats in which NAC was started prior to
BUO. (B) Immunoblots that reacted with anti-eNOS revealed 140-kDa bands.
NAC prevented (pre-BOU) and reversed (post-BUO) the
increase in TBARS. The mean serum TBARS of rats that
were anaesthetized with ether was 2.67 ± 0.15 nmol/ml,
not significantly different from the sham rats anaesthetized
with sodium pentobarbital (a barbituric acid compound),
indicating that this last anaesthetic drug does not interfere
with TBARS determinations. At 48 h after the relief of
the obstruction, rats subjected to BUO and left untreated
presented significant reductions in inulin clearance and
RBF and increase in blood pressure in comparison with
sham-operated rats and sham + NAC group. However,
in comparison with the rats subjected to BUO only,
those subjected to BUO and receiving NAC presented
less impairment of renal function. Also, we observed no
significant changes in blood pressure and a normal RBF
associated with a lower renal vascular resistance (Table 1).
It is noteworthy that the inulin clearance was higher in
sham rats treated with NAC than in the untreated sham rats.
As can be seen in Figure 1, mean eNOS protein expres-
sion was markedly lower in the rats subjected to BUO and
left untreated than in the sham-operated rats (40.7 ± 12.2%
versus 100.5 ± 9.2%, P < 0.01). However, the mean eNOS
proteinexpressionseenintheratsinwhichNACwasstarted
prior to BUO (72.5 ± 2.05%) was significantly higher than
that observed in the rats subjected to BUO only (P < 0.05).
Bilateral ureteral obstruction is associated with reduced
urine osmolality and downregulation of aquaporin
2 protein expression
Although urine osmolality was lower in all of the rats sub-
mitted to BUO than in the sham-operated untreated rats
and in sham rats that received NAC, it was higher in those
receiving NAC than in those that were left untreated.
It is well known that AQP2 protein expression decreases
after BUO. As shown in Figure 2, the mean AQP2 proteinN-acetylcysteine protects against renal injury 3071
Fig. 2. Semiquantitative immunoblotting of medullary membrane fractions 48 h after the relief of BUO. (A) Densitometric analysis of all samples
from sham-operated, untreated rats, rats subjected to BUO and left untreated, and rats in which NAC was started prior to BUO. The rats subjected
to BUO and left untreated presented decreased AQP2 protein expression. Levels of AQP2 protein expression were partially restored in rats in which
NAC was started prior to BUO. (B) Immunoblots that reacted with anti-AQP2 revealed 29-kDa bands and 35- to 50-kDa AQP2 bands, representing the
non-glycosylated and glycosylated forms of AQP2, respectively.
expression at 48 hafterBUOrelief was significantly down-
regulated in the rats subjected to BUO and left untreated in
comparison with the sham-operated rats (31.7 ± 5.2 versus
96.3 ± 3.6%, P < 0.01). However, this effect was less pro-
nounced in the rats in which NAC was started prior to BUO
(72.3 ± 1.4%).
N-acetylcysteine administration decreases interstitial area
in the bilateral ureteral obstruction model
AscanbeseeninFigure3,themeanrelativeinterstitialarea
in the group of rats subjected to BUO and left untreated
was 11.17 ± 1.11%, which was significantly higher than
the 7.69 ± 0.41% seen in rats in which NAC was started
prior to BUO (P < 0.01), and also higher than the sham
group, 7.55 ± 0.44 (P < 0.01). Figure 4 shows renal cortex
sections obtained from rats subjected to BUO only. As can
be seen, all of the tubules were dilated, and the tubular cells
were atrophied. In addition, an increase in interstitial area
was observed. All of these histological alterations were
reversed in the rats in which NAC was started prior to
BUO.
Discussion
The results of our study demonstrate that NAC administra-
tion ameliorates the renal function impairment observed 48
h after the relief of 24-h BUO. The effects of NAC included
lower serum TBARS concentrations and histological im-
provement. Most importantly, these beneficial effects were
also observed in the rats treated with NAC on the day of
the relief of obstruction, indicating that patients suffering
from obstructive nephropathies might benefit from NAC
treatment as an adjunct to surgery.
Various mechanisms might be responsible for the ben-
eficial haemodynamic effects of NAC in rats subjected to
BUO. One previous study showed that rats subjected to
24-h BUO presented post-obstruction plasma levels of
L-argininethatweresignificantlylowerthanthoseobserved
at baseline [14]. Ito et al. studied rats subjected to a 3-day
unilateralureteralobstructionandexamined7daysafterthe
reliefoftheobstruction[15].Theauthorsfoundthatdietary
supplementation with L-arginine attenuated the renal dam-
age resulting from the obstruction. Supplementation with
L-arginine also increased NO production, as evidenced by3072 M. H. M. Shimizu et al.
Fig. 3. Photomicrograph of a renal cortex section 48 h after the relief
of the obstruction. The middle panel illustrates the renal cortex of a rat
subjected to BUO and left untreated: all tubules are dilated, tubular cells
areatrophiedandtheinterstitialareaisincreased.Noneofthesealterations
wereobservedinsham(upperpanel)andinNAC-treatedrats(lowerpanel).
Magnification ×280.
an increase in the urinary excretion of NO2/NO3. In addi-
tion, fibrosis, apoptosis and macrophage infiltration were
foundtobesignificantlyreducedafter L-argininetreatment,
although GFR and RBF were unaltered, as was eNOS pro-
tein expression in renal tissue.
In our study, NAC administration attenuated the BUO-
induced decrease in renal protein expression of eNOS. This
finding indicates that, at least in part, the normalization
of GFR and RBF seen in the rats treated with NAC can be
attributedtoanincreaseinNOsynthesis.Thisalsosuggests
that other mechanisms modulate the protective effects of
NAC.
Ullianetal.showedthatantioxidants withSHgroupsare
strong reducers of disulfide bonds and inhibit the binding
of angiotensin II to its surface receptors, consequently at-
tenuating signal transduction and cellular activity [16]. The
authors found that when cultured vascular smooth muscle
cells,whichexpressangiotensinIItype1a(AT1a)receptors,
were incubated with NAC for1 h at 37◦C, angiotensin IIra-
dioligand binding decreased in a concentration-dependent
manner. They also found that NAC lowered angiotensin II
receptor binding, and that angiotensin II-stimulated signal
transduction was reduced in proportion to decreased recep-
torbinding,suggestingthatNACamelioratesrenalandvas-
cular diseases mediated by angiotensin II. This represents
another potential mechanism of the beneficial haemody-
namic effect of NAC in BUO. A possible decrease of an-
giotensin II binding to glomerular mesangial cells induced
by NAC may explain the increase in inulin clearance ob-
served in sham plus NAC-treated rats in comparison to
sham rats.
Various studies have demonstrated that angiotensin II
plays a pivotal role in the pathogenesis of obstructive
nephropathy. Jensen et al. demonstrated that the admin-
istration of candesartan, an AT1 receptor antagonist, at the
Fig. 4. Fractional interstitial area in cortex 48 h after the relief of the
obstruction of sham, sham-operated group; BUO, 24-h bilateral ureteral
obstruction (BUO) group; BUO + NAC-pre, 24-h BUO plus NAC started
2 days prior to obstruction; data are expressed as mean ± SEM.
onset of obstruction attenuates the reduction in GFR, as
well as partially preventing the downregulation of AQP2
and NKCC2 protein expression [17]. Other authors have
suggested that the downregulation of AQP channels is me-
diated via angiotensin II induction of cyclooxygenase 2
[18,19].
In the present study, we demonstrated that NAC treat-
ment improves urine osmolality by reversing BUO-induced
downregulation of AQP2. Our findings suggest that multi-
plepathwaysareinvolvedinAQPdownregulation.Wespec-
ulate that BUO-related oxidative stress triggers angiotensin
II induction of cyclooxygenase 2, thereby downregulating
AQP2 protein expression and leading to polyuria.
We observed histological improvement in rats subjected
to BUO and treated with NAC, all of which also presented
a reduction in interstitial area, as well as normalization of
tubular dilation and tubular cell atrophy. It is well known
that angiotensin II activates nuclear factor kappa B (NF-
κB) via AT1 and AT2 receptors. In turn, NF-κB activa-
tion leads to fibroblast proliferation and to the subsequentN-acetylcysteine protects against renal injury 3073
differentiation of fibroblasts into myofibroblasts. In addi-
tion, NF-κB stimulates tubular epithelial cells to produce
chemoattractants and adhesion proteins that cause inflam-
mation and produce profibrotic cytokines, thereby increas-
ingtheproductionofextracellularmatrixproteins.Working
in concert, these mechanisms lead to tubulointerstitial fi-
brosis [20]. The inhibition of NF-κB resulting from NAC
administration might constitute the mechanism by which
the interstitial area of the renal cortex was reduced in the
NAC-treated rats evaluated in the present study.
Overall, our results are in agreement with the possibility
of a pharmacological intervention in cases of urinary tract
obstruction [21].
The present study describes a novel application of NAC,
an inexpensive drug that produces no major side effects.
Clinical studies are needed in order to determine the effects
of NAC on the recovery of renal function after the relief
of obstruction, especially in patients with severe renal
failure. The practical application of such knowledge could
effectively shorten the duration of dialysis treatment in
such patients.
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